| Report ID | 280883 |
| Drug Identification Number | 02312379 |
| Brand name | DECCOX-M |
| Common or Proper name | Deccox-M |
| Company Name | PHIBRO ANIMAL HEALTH CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DECOQUINATE |
| Strength(s) | 8G |
| Dosage form(s) | DRUG PREMIX |
| Route of administration | ORAL ORAL |
| Packaging size | 8g/kg |
| ATC code | |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-04-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-20 |
| Company comments | Shortage related to Health Canada direction to stop imports of products containing API from third party supplier |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GLENPOINT CENTRE EAST, 3RD FLOOR, 300 FRANK W BURR BLVD., STE. 21 TEANECK, NEW JERSEY UNITED STATES 07666 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-20 | French | Compare |
| v1 | 2026-03-20 | English | Compare |
Showing 1 to 2 of 2